<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd" xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>00000cab a22000003a 4500</leader>
  <controlfield tag="001">UP-99796217609180368</controlfield>
  <controlfield tag="003">Buklod</controlfield>
  <controlfield tag="005">20231007234045.0</controlfield>
  <controlfield tag="006">m    |o  d |      </controlfield>
  <controlfield tag="007">ta</controlfield>
  <controlfield tag="008">100305s        xx     d | ||r |||||   ||</controlfield>
  <datafield tag="040" ind1=" " ind2=" ">
   <subfield code="a">DENGII</subfield>
  </datafield>
  <datafield tag="041" ind1=" " ind2=" ">
   <subfield code="a">eng</subfield>
  </datafield>
  <datafield tag="100" ind1="0" ind2=" ">
   <subfield code="a">Collins, D.J.</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Dynamic magnetic resonance imaging of tumor perfusion.</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
   <subfield code="a">pp. 65-83</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
   <subfield code="a">This work presents approaches and biomedical challenges of dynamic contrast enhanced magnetic resonance imaging (DCE-MRI). DCE-MRI using small molecular weight gadolinium chelates enables noninvasive imaging characterization of tissue vascularity. Depending on the technique used, data reflecting tissue perfusion (blood flow, blood volume, mean transit time), microvessel permeability surface area product, and extracellular leakage space can be obtained. Insights into these physiological processes can be obtained from inspection of kinetic enhancement curves or by the application of complex compartmental modeling techniques. Potential clinical applications include screening for malignant disease, lesion characterization, monitoring lesion response to treatment, and assessment of residual disease. Newer applications include prognostication, pharmacodynamic assessments of antivascular anticancer drugs, and predicting efficacy of treatment. For dynamic MRI to enter into widespread clinical practice, it will be necessary to develop standardized approaches to measurement and robust analysis approaches. These include the need for commercial equipment manufacturers to provide robust methods for rapidly measuring time-varying change in T1 relaxation rates, incorporation of arterial input function into kinetic modeling processes, robust analysis software that allows input from a variety of MRI devices, and validated statistical tools for the evaluation of heterogeneity.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Antivascular anticancer drugs.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Arterial input function.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Blood flow.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Blood volume.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Complex compartmental modeling techniques.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Dynamic magnetic resonance imaging.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Extracellular leakage space.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Kinetic enhancement curves.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Kinetic modeling processes.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Lesion characterization.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Malignant disease screening.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Mean transit time.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Microvessel permeability surface area product.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Noninvasive imaging characterization.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Pharmacodynamic assessments.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Prognostication.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Robust analysis software.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Small molecular weight gadolinium chelates.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Tissue perfusion.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Tissue vascularity.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Treatment efficacy.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Tumor perfusion.</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
   <subfield code="a">Validated statistical tools.</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">IEEE Engineering in medicine and biology magazine</subfield>
   <subfield code="g">23, 5 (2004).</subfield>
  </datafield>
  <datafield tag="905" ind1=" " ind2=" ">
   <subfield code="a">FO</subfield>
  </datafield>
  <datafield tag="942" ind1=" " ind2=" ">
   <subfield code="a">Article</subfield>
  </datafield>
 </record>
</collection>
